Oxidative stress has been implicated in diseases such as cancer, arthritis, nonalcoholic fatty liver disease and diabetes
Common Side Effects and Practical Safety Considerations No clinician should promise zero side effects. A more useful promise is predictable risk management. Here are the most common issues seen in peptide protocols, including stacks: 1) Injection site reactions Mild redness, itching, swelling, or tenderness can occur at the injection site
No there is no registered clinical trial of the GLOW combination
Urinary Urgency: This is a sudden, strong need to urinate that cannot be ignored
Practical & safety How many doses are in one KLOW vial
5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg/mL 250 mcg dose = 10 units (0.1 mL) on a 100-unit insulin syringe 500 mcg dose = 20 units (0.2 mL) on a 100-unit insulin syringe Doses per vial: 20 doses at 250 mcg, or 10 doses at 500 mcg Supplies Needed (8-Week Cycle at 250 mcg/day) 3 vials BPC-157 (5 mg each) provides 60 doses, covers 56 days with margin 3 vials bacteriostatic water (30 mL each) 60 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique BPC-157 goes subcutaneous (SubQ)
